StockData
PAVmed Inc. logo

PAVmed Inc. (PAVM) stock

PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.51−0.24 (-13.71%)

Close on Nov 17, 2026Market cap $12.07MP/E –Yield –

PAVmed profit margin

Profit margin (net margin) is net income as a percentage of revenue.

PAVmed's profit margin for the twelve months ending Jun 30, 2026 was -10794.6%. For fiscal 2025 it was 564.8%, against 1328.6% the year before. The highest annual figure on record is 1328.6% in fiscal 2024.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025564.8%−763.8
FY2024Dec 31, 20241328.6%+3945.8
FY2023Dec 31, 2023-2617.3%+20985.7
FY2022Dec 31, 2022-23602.9%−13533.5
FY2021Dec 31, 2021-10069.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-16315.2%+182368.2
Q1 FY2026Mar 31, 2026-272.7%−237372.7
Q4 FY2025Dec 31, 2025-2428.8%−16738.8
Q3 FY2025Sep 30, 2025-107660.0%−114125.8
Q2 FY2025Jun 30, 2025-198683.3%−197577.4
Q1 FY2025Mar 31, 2025237100.0%+238606.1
Q4 FY2024Dec 31, 202414310.0%+15648.0
Q3 FY2024Sep 30, 20246465.8%+8699.8
Q2 FY2024Jun 30, 2024-1105.9%+7651.3
Q1 FY2024Mar 31, 2024-1506.1%+2514.3
Q4 FY2023Dec 31, 2023-1338.0%+16929.8
Q3 FY2023Sep 30, 2023-2234.0%+32142.3
Q2 FY2023Jun 30, 2023-8757.2%+169.8
Q1 FY2023Mar 31, 2023-4020.4%+1718.9
Q4 FY2022Dec 31, 2022-18267.9%−12154.4
Q3 FY2022Sep 30, 2022-34376.3%–
Q1 FY2022Mar 31, 2022-8927.0%–
Q4 FY2021Dec 31, 2021-5739.3%–
Q3 FY2021Sep 30, 2021-6113.5%–

More PAVmed figures

See a number that looks wrong?